A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients-Reference-Cited by-同舟云学术

A Phase I/IIa study of autologous tolerogenic dendritic cells immunotherapy in kidney transplant recipients

Published:2023-03 Issue:3 Volume:103 Page:627-637
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Moreau Aurélie,Kervella Delphine,Bouchet-Delbos Laurence,Braudeau Cécile,Saïagh Soraya,Guérif Pierrick,Limou Sophie,Moreau Anne,Bercegeay Sylvain,Streitz Mathias,Sawitzki Birgit,James Ben,Harden Paul N.,Game David,Tang Qizhi,Markmann James F.,Roberts Ian S.D.,Geissler Edward K.,Dréno Brigitte,Josien Régis,Cuturi Maria-Cristina,Blancho Gilles,Blancho Gilles,Branchereau Julien,Cantarovich Diego,Chapelet Agnès,Dantal Jacques,Deltombe Clément,Figueres Lucile,Gaisne Raphael,Garandeau Claire,Giral Magali,Gourraud-Vercel Caroline,Hourmant Maryvonne,Karam Georges,Kerleau Clarisse,Kervella Delphine,Masset Christophe,Meurette Aurélie,Ville Simon,Kandell Christine,Moreau Anne,Renaudin Karine,Delbos Florent,Walencik Alexandre,Devis Anne

Publisher

Elsevier BV

Subject

Nephrology

Reference32 articles.

1. Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015;Coemans;Kidney Int,2018

2. Strategies for long-term preservation of kidney graft function;Wekerle;Lancet,2017

3. Now or never? The case for cell-based immunosuppression in kidney transplantation;Hutchinson;Kidney Int,2015

4. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients;Fu;Transplantation,1996

5. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo;Lutz;Eur J Immunol,2000

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leveraging current insights on IL‐10‐producing dendritic cells for developing effective immunotherapeutic approaches;FEBS Letters;2024-09-12

2. Unlocking Transplant Tolerance with Biomaterials;Advanced Healthcare Materials;2024-07-03

3. Dendritic cells and antigen-specific immunotherapy in autoimmune rheumatic diseases;Best Practice & Research Clinical Rheumatology;2024-05

4. Relationship between the microenvironment and survival in kidney transplantation: a bibliometric analysis from 2013 to 2023;Frontiers in Immunology;2024-03-26

5. Tolerogenic CD11c⁺dendritic cells regulate CD4⁺Tregs in replacing delayed ischemic preconditioning to alleviate ischemia–reperfusion acute kidney injury;The FASEB Journal;2024-03-26